Breakingviews
Tuesday, September 20, 2016
Breakingviews: Laboratory conditions
Robert Cyran tells Richard Beales why Abbott Labs' $4.3 bln asset sale to J&J eases pressure on the two tricky acquisitions totaling over $30 bln that it has in the pipeline.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment